Stockreport

Mirum (MIRM) Soars on Interim Data From Liver Disease Studies [Yahoo! Finance]

Acrivon Therapeutics, Inc.  (ACRV) 
PDF evaluated its oral ileal bile acid transporter inhibitor, volixibat, for treating patients with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC [Read more]